This study was designed to explore the expression level of MFN2 in the cancer tissues of patients with hepatitis B-related HCC, analyze the relationship between the expression level of MFN2 and clinicopathological features, and investigate its role in the regulation of hepatitis B-related HCC. The gene discussed is MFN2; the disease is cancer.